Department of Orthopaedics, Xinqiao Hospital of Third Military Medical University, Chongqing, Shapingba District, People's Republic of China; Department of Orthopaedics, Fourth Military of Chinese People Liberation Army, Xining, Qinghai, China.
Department of Orthopaedics, Xinqiao Hospital of Third Military Medical University, Chongqing, Shapingba District, People's Republic of China.
World Neurosurg. 2018 Jan;109:e761-e769. doi: 10.1016/j.wneu.2017.10.077. Epub 2017 Oct 23.
Recurrent symptoms of sciatica after previous surgical intervention is a relatively common and troublesome clinical problem. Percutaneous endoscopic lumbar decompression has been proved to be an effective method for recurrent lumbar disc herniation. However, the prognostic factors and outcomes of percutaneous endoscopic lumbar reoperation (PELR) for recurrent sciatica symptoms were still unknown. The purpose of this study was to evaluate the outcomes and prognostic factors of patients who underwent PELR for recurrent sciatica symptoms.
From 2009 to 2015, 94 patients who underwent PELR for recurrent sciatica symptoms were enrolled. The primary surgeries include transforaminal lumbar interbody fusion (n = 16), microendoscopic discectomy (n = 31), percutaneous endoscopic lumbar decompression (PELD, n = 17), and open discectomy (n = 30). The mean follow-up period was 36 months, and 86 (91.5%) patients had obtained at least 24 months' follow-up.
Of the 94 patients with adequate follow-up, 51 (54.3%) exhibited excellent improvement, 23 (24.5%) had good improvement, and 7 (7.4%) had fair improvement according to modified Macnab criteria. The average re-recurrence rate was 9.6%, with no difference among the different primary surgery groups (PELD, 3/17; microendoscopic discectomy, 2/31; open discectomy, 3/30; transforaminal lumbar interbody fusion, 1/16). There was a trend toward greater rates of symptom recurrence in the primary group of PELD who underwent percutaneous endoscopic lumbar reoperation compared with other groups, but this did not reach statistical significance (P > 0.05). Multivariate analysis suggested that age, body mass index, and surgeon level was independent prognostic factors. Obesity (hazard ratio 13.98, 95% confidence interval 3.394-57.57; P < 0.001) was the risk factor affecting re-recurrence according to logistic regression analysis.
PELR is a safe and effective treatment for recurrent sciatica symptoms regardless of different primary operation type. Obesity, inferior surgeon level, and patient age older than 40 years were associated with a worse prognosis. Obesity was also a strong and independent predictor of re-recurrence sciatica symptoms after percutaneous endoscopic lumbar decompression.
既往手术干预后出现复发性坐骨神经痛症状是一个相对常见且麻烦的临床问题。经皮内镜腰椎减压术已被证明是治疗复发性腰椎间盘突出症的有效方法。然而,对于复发性坐骨神经痛症状行经皮内镜腰椎再手术(PELR)的预后因素和结果仍不清楚。本研究旨在评估复发性坐骨神经痛症状行 PELR 的患者的结果和预后因素。
2009 年至 2015 年,共纳入 94 例因复发性坐骨神经痛症状而行 PELR 的患者。初次手术包括经椎间孔腰椎体间融合术(n=16)、显微镜下椎间盘切除术(n=31)、经皮内镜腰椎减压术(PELD,n=17)和开放椎间盘切除术(n=30)。平均随访时间为 36 个月,86 例(91.5%)患者获得至少 24 个月的随访。
在 94 例有充分随访的患者中,根据改良 Macnab 标准,51 例(54.3%)改善优秀,23 例(24.5%)改善良好,7 例(7.4%)改善一般。平均复发率为 9.6%,不同初次手术组之间无差异(PELD,3/17;显微镜下椎间盘切除术,2/31;开放椎间盘切除术,3/30;经椎间孔腰椎体间融合术,1/16)。初次手术为 PELD 的患者再次接受经皮内镜腰椎再手术的症状复发率有增加的趋势,但未达到统计学意义(P>0.05)。多因素分析提示年龄、体重指数和术者水平是独立的预后因素。肥胖(风险比 13.98,95%置信区间 3.394-57.57;P<0.001)是根据逻辑回归分析影响再复发的危险因素。
PELR 是治疗复发性坐骨神经痛症状的一种安全有效的方法,与不同的初次手术类型无关。肥胖、术者水平较低以及年龄大于 40 岁与预后较差相关。肥胖也是经皮内镜腰椎减压术后复发坐骨神经痛症状的一个强而独立的预测因素。